BCRX BioCryst Pharmaceuticals, Inc.
$8.90
▲ 0.79%
45
Value
18
P/E-4.71
8
P/B-3.89
5
P/S2.11
60
EV/EBITDA-4.57
5
Growth
89
Revenue Growth94.1%
100
EPS Growth393.0%
70
FCF Growth716.1%
100
Momentum
59
12-Month Return-13.3%
37
3-Month Return42.6%
100
1-Month Return-9.0%
37
RSI (14)38.64
50
50/200 MABullish
75
Profitability
38
ROE123.6%
75
ROA-98.5%
0
Gross Margin18.9%
26
Operating Margin-43.1%
0
Net Margin-51.7%
0
FCF Yield15.8%
100
Risk
25
Beta0.57
55
60-Day Volatility50.7%
0
QScore Analysis